Director of Business Development
Consumer Engagement and Research Services
Posted on 7/19/2023
INACTIVE
23andMe

501-1,000 employees

Personal genomics & biotechnology company
Company Overview
23andMe’s mission is to help people access, understand, and benefit from the human genome. The company has created the world’s largest crowdsourced platform for genetic research and is the only company with multiple FDA authorizations for genetic health risk reports. The company is also in development of discovery programs rooted in a diverse spectrum of human genetics to ultimately deliver reports and results from all spectrums of your DNA.
Biotechnology

Company Stage

N/A

Total Funding

$1.2B

Founded

2006

Headquarters

Sunnyvale, California

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

-6%

2 year growth

16%
Locations
Sunnyvale, CA, USA
Experience Level
Entry
Junior
Mid
Senior
Expert
CategoriesNew
Biology & Biotech
Business & Strategy
Requirements
  • Bachelor's, preferably in the life sciences. MD/PhD or MS+MBA in a relevant field preferred
  • A minimum of 10 years of experience in business development. 5+ years in a senior strategic role
  • Strong track record of sourcing, negotiating, and closing partnerships with positive results
  • Direct exposure to commercial teams, product planning, and late stage development projects in biotech/pharma
  • Extensive network of industry contacts
  • Experience in multiple therapeutic areas is preferred
  • Strategic thinking with outstanding business instincts, can help chart the course and can translate plans into value-creating results for the company
  • Ability to apply critical, strategic, and scientific/technical thinking to unstructured situations to make sound business judgments
  • Demonstrated ability to lead projects and teams with attention to detail, and to influence without authority
  • Resourceful self-starter with strong alignment with 23andMe's core values
  • Ability to work effectively in a dynamic, entrepreneurial environment and a bias towards 'win-win' collaboration at all levels